Cargando…

Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

Psoriasis is a type I–deviated disease characterized by the presence of interferon (IFN)-γ and multiple IFN-related inflammatory genes in lesions. Because interleukin (IL)-23 is now recognized to play a role in the recruitment of inflammatory cells in a T helper cell (Th)1-mediated disease, we exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Edmund, Trepicchio, William L., Oestreicher, Judith L., Pittman, Debra, Wang, Frank, Chamian, Francesca, Dhodapkar, Madhav, Krueger, James G.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887731/ https://www.ncbi.nlm.nih.gov/pubmed/14707118 http://dx.doi.org/10.1084/jem.20030451

Ejemplares similares

Indirect Regulation and Equilibrium of p35 and p40 Subunits of Interleukin (IL)-12/23 by Ustekinumab in Psoriasis Treatment
por: Zhou, Jiong, et al.
Publicado: (2020)

Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series
por: Lowes, Michelle A, et al.
Publicado: (2007)

Overexpression of Interleukin-23 and Interleukin-17 in the Lesion of Pemphigus Vulgaris: A Preliminary Study
por: Xue, Jixin, et al.
Publicado: (2014)

Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
por: Starek, Jéssica Vianna, et al.
Publicado: (2021)

Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris
por: Bacaksiz, Ahmet, et al.
Publicado: (2013)

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities
por: Menter, Alan, et al.
Publicado: (2021)

Plasma Interleukin-18 and Dendritic Cells in Males with Psoriasis Vulgaris
por: Pietrzak, Aldona, et al.
Publicado: (2007)

Ferroptosis Activation Contributes to the Formation of Skin Lesions in Psoriasis Vulgaris
por: Li, Siying, et al.
Publicado: (2023)

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
por: Johansson, Per, et al.
Publicado: (2017)

Dendritic cells resist to disulfiram-induced cytotoxicity, but reduced interleukin-12/23(p40) production
por: Jung, Haebeen, et al.
Publicado: (2023)

Rheumatoid Arthritis and Psoriasis Vulgaris
por: Boisvert, Paul L.
Publicado: (1956)

Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
por: Yajima, Makiko, et al.
Publicado: (2019)

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
por: Schön, Michael P., et al.
Publicado: (2018)

Transcriptomic Profiling of Peripheral Edge of Lesions to Elucidate the Pathogenesis of Psoriasis Vulgaris
por: Boonpethkaew, Suphagan, et al.
Publicado: (2022)

Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)

Enhanced serum interferon-lambda 1 interleukin-29 levels in patients with psoriasis vulgaris()()
por: Fu, Li-xin, et al.
Publicado: (2021)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
por: Koutruba, Nora, et al.
Publicado: (2010)

Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?
por: Ergen, Elizabeth N., et al.
Publicado: (2018)

Psoriasis Vulgaris in Children - Case Presentation
por: SINGER, C., et al.
Publicado: (2016)

The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
por: Kim, Jaehwan, et al.
Publicado: (2022)

Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways
por: Espígol-Frigolé, Georgina, et al.
Publicado: (2018)

Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia
por: Bedrossian, Nora, et al.
Publicado: (2016)

Elevated Plasma Levels of Interleukin-12p40 and Interleukin-16 in Overweight Adolescents
por: Lichtenauer, Michael, et al.
Publicado: (2015)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
por: Crowley, J.J., et al.
Publicado: (2019)

Evaluation of interleukin-23 receptor (IL-23R) gene polymorphisms and serum IL-23 levels in patients with psoriasis
por: FİLİZ, Başak, et al.
Publicado: (2019)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
por: Cauli, Alberto, et al.
Publicado: (2015)

Multiple drugs: COVID-19, psoriasis vulgaris flare-up and exacerbation of psoriasis vulgaris led to erythrodermic psoriasis: 2 case reports
Publicado: (2022)

Serum Prolactin Levels in Psoriasis Vulgaris
por: Handjani, Farhad, et al.
Publicado: (2014)

The role of hormones in the pathogenesis of psoriasis vulgaris
por: ROMAN, IULIA IOANA, et al.
Publicado: (2016)

Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris
por: Visser, Maria J. E., et al.
Publicado: (2019)

The study of GSDMB in pathogenesis of psoriasis vulgaris
por: Ji, Xiaojuan, et al.
Publicado: (2023)

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
por: Egeberg, A., et al.
Publicado: (2020)

Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis
por: Chamian, Francesca, et al.
Publicado: (2007)

Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases
por: Vincken, Nanette L. A., et al.
Publicado: (2022)

TRB3 is elevated in psoriasis vulgaris lesions and mediates HaCaT cells proliferation in vitro
por: Yu, Xiao-Jing, et al.
Publicado: (2017)

Psoriasis Vulgaris: Report on a Case Showing Skin, Joint and Eye Lesions (Keratitis Psoriatica)
por: Horowitz, S.
Publicado: (1949)

Transcriptome-Wide m(6)A Methylation in Skin Lesions From Patients With Psoriasis Vulgaris
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
por: Avallone, Gianluca, et al.
Publicado: (2023)

Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line
Publicado: (1991)

Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pbsetf332ifqtun58vf7avgmkr